Frontlight ResearchEarly access
Metastatic breast cancer trials in Brazil
1 of 18 trials · From ClinicalTrials.gov, checked 18 November 2026. Ask the study team whether a trial fits you.
- No phaseTaking peopleMinimally Interventional Study on Prevalence of Emerging ESR1 Mutations in Liquid Biopsy in Three Cohorts of Patients With Breast Cancer in Comparison With Patient's Baseline ESR1 Mutation Status as Defined by Tissue Profiling.
- Where
- Porto Alegre, Salvador, São Paulo
- Age
- 18 years to 100 years
- People
- 170
- Run by
- AstraZeneca
See details and how to joinNCT06417801